Yale researchers identify potential osteoarthritis treatment using epilepsy drug

Researchers at Yale have found that the epilepsy drug lacosamide can help reverse cartilage damage in osteoarthritis by blocking a protein involved in both pain signaling and cartilage destruction.

Why it matters. Millions of people with osteoarthritis could benefit from a new treatment that not only reduces pain but also reverses joint damage, potentially avoiding joint reconstruction procedures.